Previous Close | 19.30 |
Open | 19.15 |
Bid | 19.35 x 800 |
Ask | 21.00 x 800 |
Day's Range | 19.12 - 20.22 |
52 Week Range | 9.26 - 29.59 |
Volume | |
Avg. Volume | 254,440 |
Market Cap | 542.785M |
Beta (5Y Monthly) | 0.96 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -2.84 |
Earnings Date | Feb 26, 2024 - Mar 01, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 33.00 |
Subscribe to Yahoo Finance Plus to view Fair Value for CSTL
FRIENDSWOOD, Texas, December 01, 2023--Castle announced the publication of a new study that assessed the viewpoints of NPs/PAs toward the clinical use of DecisionDx®-Melanoma.
Last week, Castle Biosciences, Inc. ( NASDAQ:CSTL ) insiders, who had purchased shares in the previous 12 months were...
FRIENDSWOOD, Texas, November 14, 2023--Castle announced that data spanning its dermatologic portfolio of GEP tests was recently presented at the 2023 ASDS Annual Meeting.